Lion TCR announced that its mRNA-encoded T-cell receptor (TCR)-T cell therapy product Liocyx-M004 has received clearance from ...
Gilead Sciences, Inc. (Nasdaq: GILD) announced today its results of operations for the fourth quarter and full year 2024.
Health on MSN9h
There's a Chance Your Favorite Berries May Be Contaminated With Norovirus. The FDA Is Trying to Make Them SaferFact checked by Nick Blackmer The FDA has recently announced a new plan to improve the safety of imported berries.Fresh and ...
NanoViricides, Inc. (NYSE American:NNVC) (the “Company”) declared today that it is ready to fight the bird flu with its revolutionary broad-spectrum antiviral drug NV-387, a drug that the Bird Flu ...
In part, the guidance is updated to reflect differences for equine parvovirus-hepatitis and equine hepacivirus ...
Savage resident Edwin Tan spent his summer carrying a message across the triathlon finish line. Tan, 29, lives with chronic hepatitis B. He said there isn’t a lot of public ...
University of Wisconsin-Madison’s University Health Services (UHS) sent out an email to 4,000 students and staff Friday ...
Biotech giant Gilead Sciences, Inc. GILD is scheduled to report fourth-quarter and full-year 2024 results on Feb. 11, after ...
Many readers wrote to express their strong opposition to Robert F. Kennedy Jr.’s nomination to head the Department of Health and Human Services, which this week cleared a Senate committee vote and ...
The viral illness kills more people in the city than HIV, but antiviral medications may be helping cut its transmission.
For patients with hepatitis B virus, alcohol is associated with dose-dependent increased risks for cirrhosis and hepatocellular carcinoma.
GSK is prioritizing development of its hepatitis B treatment bepirovirsen as the pharma ends work on another potential ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback